Fritextsökning
Innehållstyper
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Ny chef på Sectra
Mats Franzén är ny finanschef på medtechbolaget.
-
Neurovive inleder fas II-studie
Första patienten rekryterad till studien Ciprics, på akut njurskada vid hjärtkirurgi.
-
Printing sensors for biological samples
Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Platelet analysis in whole blood
The new Multiplate analyzer from Triolab uses impedance aggregometry to measure the effects of platelet inhibitors on whole blood.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
KI Innovations säljer projekt
Smartwise köper medtechprojektet Extroducer.
-
Nina Rawal utvald till Young global leaders
Industrifondens Nina Rawal har tagits ut till World economic forums prestigefulla ledarprogram.
-
Measure blood sugar without finger pricking
The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a sma...
-
Grönt ljus för indiskt köp
Recipharm får klartecken för köpet av kontraktstillverkaren Nitin.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
Genombrott för patentlagar i USA
Nu blir det lättare för europeiska företag att söka patent i USA.
-
Partnering offer for scientists and medics
For the first time in the history of Biotech Forum, scientists and medics are invited to join the partnering event. I
-
Genombrott för patentlagar i USA
Nu blir det lättare för europeiska företag att söka patent i USA.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
OpenMM ny standard för molekylsimuleringar på grafikkort
Vijay Pandes grupp på Stanford University har nu utvecklat Open Molecular Modeling (OpenMM), en ny standard för molekylsimuleringar på grafikkort.
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
Novo och Astra ligger bra till i internationell kraftmätning
Patentutgångar kommer under de närmaste åren att drabba flera stora läkemedelsbolag, men Astrazeneca och Novo Nordisk hör till de som skymtar ljusglimtar enligt en analys.
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Hon tar Wall Street till Sverige
”Svenska entreprenörer måste bli bättre på att sälja.” Det tycker Barbro Ehnbom, ordförande för investerarmötet SALSS. Som ekonom med ena foten i den svenska li...
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
BREAKING